Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3823571 | Progrès en Urologie | 2011 | 6 Pages |
Abstract
Clinical presentation, behaviour and work-up for HCG-producing seminoma should be the same as for non-secreting seminoma. HCG-producing seminoma tumours are not more resistant to radiation therapy or chemotherapy than non-secreting seminoma tumours. Radiotherapy remains an excellent option in stage I and IIA disease with chemotherapy as an alternative; overall prognosis is excellent. Surveillance in early stage HCG-producing seminoma is followed by a higher relapse than in early stage non-secreting seminoma.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
N. Boujelbene, M. Ozsahin, G. Ugurluer, M.P. Gaye, R.O. Mirimanoff, A. Zouhair,